nejm tirzepatide for Obesity Treatment and Diabetes Prevention surmount-1 tirzepatide weight loss percent

Retatrutide: Why the Triple-Receptor Approach Is Getting Attention Retatrutide is attracting attention because it is being studied as a triple hormone receptor agonist

Patients should maintain consistency in their supplementation schedule and avoid taking supplements on an empty stomach if they experience nausea, a common side effect of Zepbound

Meta-analysis of individual participant data: rationale, conduct, and reporting

Clin Exp Pharmacol Physiol (2001) 28:559

A large proportion of GLP-1 candidates present with non-alcoholic fatty liver disease (NAFLD), now more precisely termed metabolic-associated fatty liver disease (MAFLD)